Literature DB >> 11232707

Human toxocariasis and pyogenic liver abscess: a possible association.

A A Rayes1, D Teixeira, J C Serufo, V Nobre, C M Antunes, J R Lambertucci.   

Abstract

OBJECTIVES: To study the role of human toxocariasis in the pathogenesis of pyogenic liver abscess.
METHODS: We compared the serology for toxocariasis and serum levels of IgE in 16 patients with pyogenic liver abscess to those in 32 matched (age and gender) controls to define the possible association between these two entities.
RESULTS: The serology for toxocariasis was positive in 10 of 16 patients compared with 4 of 32 controls. The relative odds and 95% confidence interval (conditional logistic regression), comparing cases and matched controls, was significant (1.4; 95% confidence interval, 1.1-1.7) for Toxocara serology. Regarding IgE serum levels, there was no difference between cases and controls.
CONCLUSIONS: Human toxocariasis can be one of the predisposing causes of pyogenic liver abscess, especially in tropical countries in which this parasitic disease is common. Treatment of human toxocariasis may prevent morbid complications like hepatic abscess and should be considered in patients with clinical and/or serological evidence of Toxocara infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11232707     DOI: 10.1111/j.1572-0241.2001.03471.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  3 in total

1.  A patient who presented with abdominal pain and eosinophilia.

Authors:  Başak Koç; Gürcan Dikme; Nihal Özdemir; Bülent Zülfikar
Journal:  Turk Pediatri Ars       Date:  2016-03-01

Review 2.  Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects.

Authors:  Dickson Despommier
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

Review 3.  Pet roundworms and hookworms: a continuing need for global worming.

Authors:  Donato Traversa
Journal:  Parasit Vectors       Date:  2012-05-10       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.